News

2026 Jan 12

Whole-Genome Sequencing May Optimize PARP Inhibitor Use

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine... Read more

2026 Jan 05

Cornell-Developed Particles Supercharge Cancer Immunotherapy

By Syl Kacapyr A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the effectiveness of... Read more

illustration of stem cells differentiating into B cells

2025 Dec 29

B Cells Transiently Unlock Their Plasticity, Risking Lymphoma Development

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more flexible, or plastic, stem-... Read more

2025 Dec 17

Research Matters: How Folate Deficiency May Alter Genes to Promote Cancer

Video of Folate deficiency: How it can rewrite your genes and fuel cancer Genetic alterations lie at the heart of cancer development, but scientists may have been overlooking a powerful driver of these changes—the everyday... Read more

2025 Dec 02

Research Matters: Personalizing Pancreatic Cancer Treatment

Video of Research Matters: Personalizing Pancreatic Cancer Treatment It’s not surprising that pancreatic cancer is often referred to as a silent killer. With few early symptoms and an aggressive nature, it has one of the... Read more

2025 Nov 20

Scientists Identify a Molecular Switch to a Painful Side Effect of Chemotherapy

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why many cancer patients experience debilitating pain as a side effect, according to a new study by... Read more

2025 Nov 17

Reviving Exhausted Immune Cells Boosts Tumor Elimination

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body’s immunity. The study led by Weill Cornell Medicine... Read more

2025 Nov 12

Infographic: Stomach Cancer Awareness

Though stomach cancer cases have dropped in the past decade, more than 30,000 Americans get the disease every year, according to the American Cancer Society. Download the guide or review the infographic below. Read more

2025 Nov 03

Researchers Unveil a Powerful New Gene-Switch Tool

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of any gene in a cell. Such “gene-switch” tools allow scientists to “turn on” or “turn off” a target... Read more

2025 Oct 15

New Mobile Lung Cancer Screening Unit Launches to Improve Access to Care for New Yorkers

A state-of-the-art health screening van launched this month is bringing advanced imaging technology and health education directly to New Yorkers who are at the greatest risk of developing lung cancer. The initiative — a... Read more

2025 Oct 14

Galvanizing Blood Vessel Cells to Expand for Organ Transplantation

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for... Read more

colored dots representing individual cells

2025 Oct 10

Cancer Progression Illuminated by New Multi-Omics Tool

A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells... Read more

Two scientists conducting research in a lab

2025 Oct 07

Research at Risk: Rooting Out Treatment-Resistant Prostate Cancer

Video of Research at Risk: Rooting out treatment-resistant prostate cancer Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease . Yet doctors and scientists have... Read more

2025 Oct 03

Study Finds Restoring Order to Dividing Cancer Cells May Prevent Metastasis

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest to treat breast cancers, but a new study led by Weill Cornell Medicine suggests a way to stop it from spreading. Researchers have discovered that... Read more

The illustration depicts part of the process where a small guide RNA delivers a protein bearing a special amino acid to the desired region. Exposure to UV light then crosslinks the amino acid to nearby proteins. Credit: Dr. Jiajun Zhu

2025 Oct 02

New Tool Identifies Proteins That Control Gene Activity

The SCOPE system can capture proteins binding to regions of DNA that control gene expression. The illustration depicts part of the process where a small guide RNA delivers a protein bearing a special amino acid to the... Read more

2025 Aug 14

Two Weill Cornell Medicine Scientists Selected for 2025 Pew Awards

Weill Cornell Medicine faculty member Dr. Anna Nam and postdoctoral fellow Dr. Maria Cecilia Lira have been chosen to join the 2025 class of Pew scholars and fellows. Dr. Nam, an assistant professor of pathology and... Read more

2025 Aug 11

What’s Melanoma? A Primer on This Dangerous Skin Cancer

Skin cancer is the most common type of cancer in America. Melanoma skin cancer is the least common type, making up only 1 out of 100 skin cancers, according to the American Cancer Society . If it’s so rare, what’s the big... Read more

2025 Aug 11

Laura Pinheiro, PhD, MPH, Appointed to Co-Lead Community Outreach and Engagement at the Sandra and Edward Meyer Cancer Center

The Sandra and Edward Meyer Cancer Center (MCC) of Weill Cornell Medicine and NewYork - Presbyterian Hospital has appointed Laura Pinheiro, PhD, MPH to join Erica Phillips, MD in co-leading the Center’s Office of Community... Read more

2025 Jul 31

Not All Low-Grade Prostate Cancers Are Low Risk

A new study reveals that some men who are diagnosed with “Grade Group one” (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University... Read more

2025 Jul 29

Uncovering How a Molecule Responsible for Immune “Brakes” Directs Skin Defenses

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early... Read more